HSBC HOLDINGS PLC

Position in KURA — Kura Oncology, Inc.

CIK 873630 LONDON, X0

Position in KURA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,040,065

+$316,235 QoQ

Shares Held

94,810

+6.5% QoQ

Ownership

0.107%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#78

of 220 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. KURA ranks #44 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	676,247	$335,912,169
2	REGN	Regeneron Pharmaceuticals, Inc.	382,028	$238,209,735
3	INCY	Incyte Corp	1,307,743	$148,245,744
4	RPRX	Royalty Pharma plc	1,224,925	$68,681,542
5	MRNA	Moderna, Inc.	636,199	$44,553,014
6	ALNY	Alnylam Pharmaceuticals, Inc.	115,279	$34,702,435
7	INSM	INSMED Inc	279,961	$29,849,438
8	BMRN	Biomarin Pharmaceutical Inc	307,543	$17,597,610

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,040,065	94,810	+6.5%	Shares	Defined	2026-08-14
2026-03-31	$723,830	89,032	+71.2%	Shares	Defined	2026-04-30
2025-12-31	$540,311	52,003	-60.4%	Shares	Defined	2026-03-06
2025-09-30	$1,161,049	131,192	-4.3%	Shares	Defined	2025-11-13
2025-06-30	$790,928	137,076	+151.6%	Shares	Defined	2025-08-13
2025-03-31	$359,640	54,491	+26.5%	Shares	Defined	2025-05-14
2024-12-31	$375,269	43,085	+166.6%	Shares	Sole	2025-02-14
2024-09-30	$315,824	16,163	-11.7%	Shares	Sole	2024-11-14
2024-06-30	$376,796	18,300	+13.4%	Shares	Defined	2024-08-12
2024-03-31	$344,116	16,133	-57.3%	Shares	Defined	2024-05-15
2023-12-31	$543,937	37,826	+13.8%	Shares	Defined	2024-02-12
2023-09-30	$303,120	33,237	+440.7%	Shares	Sole	2023-11-13
2020-12-31	$200,761	6,147	—	Shares	Defined	2021-02-25
No filing history on record for this holder in this stock.